Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Basra, Sukhdeep S., Wang, Tracy Y., Simon, DaJuanicia N., Chiswell, Karen, Virani, Salim S., Alam, Mahboob, Nambi, Vijay, Denktas, Ali E., Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M., Peterson, Eric D., Jneid, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220549/
https://www.ncbi.nlm.nih.gov/pubmed/29886424
http://dx.doi.org/10.1161/JAHA.117.008125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220549/
https://www.ncbi.nlm.nih.gov/pubmed/29886424
http://dx.doi.org/10.1161/JAHA.117.008125

Ejemplares similares